175 related articles for article (PubMed ID: 1951181)
1. Late follow-up of a short-term intensive regimen for Ewing's sarcoma.
Marcus RB; Springfield DS; Graham-Pole JR; Heare TC; Enneking WF; Million RR
Am J Clin Oncol; 1991 Oct; 14(5):446-50. PubMed ID: 1951181
[TBL] [Abstract][Full Text] [Related]
2. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
[TBL] [Abstract][Full Text] [Related]
3. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study.
Evans RG; Nesbit ME; Gehan EA; Garnsey LA; Burgert O; Vietti TJ; Cangir A; Tefft M; Thomas P; Askin FB
J Clin Oncol; 1991 Jul; 9(7):1173-80. PubMed ID: 2045857
[TBL] [Abstract][Full Text] [Related]
4. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
[TBL] [Abstract][Full Text] [Related]
5. Results of multimodal therapy in Ewing's sarcoma: a retrospective analysis of 20 patients.
Ben-Arush M; Kuten A; Perez-Nahum M; Cohen Y; Bialik V
J Surg Oncol; 1991 Sep; 48(1):51-5. PubMed ID: 1890840
[TBL] [Abstract][Full Text] [Related]
6. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.
Evans R; Nesbit M; Askin F; Burgert O; Cangir A; Foulkes M; Gehan E; Gilula L; Kissane J; Makley J
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):129-36. PubMed ID: 3881374
[TBL] [Abstract][Full Text] [Related]
7. Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
Nilbert M; Saeter G; Elomaa I; Monge OR; Wiebe T; Alvegård TA
Acta Oncol; 1998; 37(4):375-8. PubMed ID: 9743460
[TBL] [Abstract][Full Text] [Related]
8. Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients.
Kinsella TJ; Glaubiger D; Diesseroth A; Makuch R; Waller B; Pizzo P; Glatstein E
Int J Radiat Oncol Biol Phys; 1983 Dec; 9(12):1955-60. PubMed ID: 9463099
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.
Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966
[TBL] [Abstract][Full Text] [Related]
10. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy.
Bacci G; Toni A; Avella M; Manfrini M; Sudanese A; Ciaroni D; Boriani S; Emiliani E; Campanacci M
Cancer; 1989 Apr; 63(8):1477-86. PubMed ID: 2924256
[TBL] [Abstract][Full Text] [Related]
11. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.
Nesbit ME; Gehan EA; Burgert EO; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P; Askin FB; Kissane JM
J Clin Oncol; 1990 Oct; 8(10):1664-74. PubMed ID: 2213103
[TBL] [Abstract][Full Text] [Related]
12. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81.
Sauer R; Jürgens H; Burgers JM; Dunst J; Hawlicek R; Michaelis J
Radiother Oncol; 1987 Oct; 10(2):101-10. PubMed ID: 3423301
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy.
Kinsella TJ; Miser JS; Waller B; Venzon D; Glatstein E; Weaver-McClure L; Horowitz ME
Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):389-95. PubMed ID: 1995522
[TBL] [Abstract][Full Text] [Related]
15. Multimodal therapy for children and adolescents with Ewing sarcoma: results of the First National Chilean Trial (1986-1991).
Villarroel M; Tordecilla J; Salgado C; Luo X; Messen S; Rayo Y; Zolezzi P; Rojas J
Med Pediatr Oncol; 1997 Sep; 29(3):190-6. PubMed ID: 9212843
[TBL] [Abstract][Full Text] [Related]
16. [Therapy results of the British ET-1 study for Ewing's sarcoma].
Dunst J
Strahlenther Onkol; 1998 May; 174(5):289-90. PubMed ID: 9614962
[No Abstract] [Full Text] [Related]
17. Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG).
Shankar AG; Pinkerton CR; Atra A; Ashley S; Lewis I; Spooner D; Cannon S; Grimer R; Cotterill SJ; Craft AW
Eur J Cancer; 1999 Nov; 35(12):1698-704. PubMed ID: 10674016
[TBL] [Abstract][Full Text] [Related]
18. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
Kushner BH; Meyers PA
J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C
Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366
[TBL] [Abstract][Full Text] [Related]
20. Ewing's sarcoma.
Iyer RS; Rao SR; Gurjal A; Nair CN; Pai SK; Kurkure PA; Pande SC; Advani SH
J Surg Oncol; 1993 Mar; 52(3):188-92. PubMed ID: 8441279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
